NCT07383077

Brief Summary

This study main aim is to identify molecular determinants of better recovery following spinal cord injury (SCI), as biomarkers of neurological and/or functional improvement and a proxy for neuroregeneration. For that, omics analyses of several biological samples will be performed, to comprehensively portray the molecular and cellular profiles of the patients with SCI at key time points of the pathology: pre-rehabilitation, post-rehabilitation and one-year post-injury. The main question it aims to answer is: 'Are there specific molecules (and related biological pathways) that impact the functional recovery of spinal cord injury patients during the subacute phase, in a way that future targeted pharmacological or genetic interventions may improve SCI outcomes?'.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2021

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 16, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 16, 2023

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

January 17, 2026

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 3, 2026

Completed
Last Updated

February 3, 2026

Status Verified

January 1, 2026

Enrollment Period

2.5 years

First QC Date

January 17, 2026

Last Update Submit

January 28, 2026

Conditions

Keywords

Spinal Cord InjuryRehabilitationRegenerationOmicsBiomarkersTherapeutic targetsTranslational

Outcome Measures

Primary Outcomes (2)

  • Molecular/cellular candidate biomarkers with a strong association to functional independence

    Association between functional independence, assessed by the Spinal Cord Independence Measure, 4th version (SCIM IV), and by the Functional Independence Measure (FIM), with levels of specific molecular or cellular candidate biomarkers. Association studies will consider functional independence measures (at admission, their variation, and/or at discharge) and specific molecular or cellular candidate biomarkers, such as protein or bacterial levels (at admission, their variation, and/or at discharge).

    From admission into the rehabilitation hospital (~2 months post-injury) until discharge (~4 months post-injury)

  • Molecular/cellular candidate biomarkers with a strong association to neuromotor impairment

    Association between total motor scores, assessed by the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI), with levels of specific molecular or cellular candidate biomarkers. Association studies will consider ISNCSCI motor scores (at admission, their variation, and/or at discharge) and specific molecular or cellular candidate biomarkers, such as protein or bacterial levels (at admission, their variation, and/or at discharge).

    From admission into the rehabilitation hospital (~2 months post-injury) until discharge (~4 months post-injury)

Secondary Outcomes (2)

  • Molecular/cellular candidate biomarkers identified in the primary outcome measures with a strong association to neurological impairment

    From admission into the rehabilitation hospital (~2 months post-injury), across discharge (~4 months post-injury), and until follow-up (1-year post-injury)

  • Longitudinal profiles of key molecules (and bacteria) across post-intensive inpatient rehabilitation, and a period post-discharge (subacute and chronic phases)

    From admission into the rehabilitation hospital (~2 months post-injury), across discharge (~4 months post-injury), and until follow-up (1-year post-injury)

Study Arms (2)

SCI cohort

Spinal cord injury patients admitted for hospitalization at Centro de Reabilitação do Norte, Unidade Local de Saúde de Gaia e Espinho, E.P.E. categorized into two subgroups: with A or B (motor complete injuries) classification, or with C or D (motor incomplete) classification in The American Spinal Injury Association (ASIA) Impairment Scale (AIS).

Able-bodied controls

Age, sex and body mass index-matched control group of participants recruited among able-bodied personnel from Centro de Reabilitação do Norte, Unidade Local de Saúde de Gaia e Espinho, E.P.E. or their relatives, without any known CNS disease.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients admitted to the North Rehabilitation Center ("Centro de Reabilitação do Norte, CRN-ULSGE") between 1st of May 2021 and 16th of October 2023, following a traumatic spinal cord injury.

You may qualify if:

  • Clinically diagnosed with traumatic spinal cord injury
  • Adults (≥18 years).
  • Injury occurred less than 6 months ago (subacute phase).
  • Classification A-D in The American Spinal Injury Association (ASIA) Impairment Scale (AIS).
  • Any neurological level of injury.

You may not qualify if:

  • Use of probiotics one-month prior admission.
  • Use of immunomodulatory drugs one-month prior admission.
  • Major gastrointestinal surgery in the last five years.
  • Active gastrointestinal diseases.
  • Other CNS diseases (besides SCI).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro de Reabilitação do Norte (CRN) / Unidade Local de Saúde Gaia e Espinho, E.P.E. (ULSGE), Vila Nova de Gaia,, Portugal

Vila Nova de Gaia, 4405-565 Vila Nova de Gaia, Portugal

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood, urine and fecal samples

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Sandra I. Vieira, Prof. Dr.

    Institute of Biomedicine, Department of Medical Sciences, University of Aveiro (iBiMED-UA)

    PRINCIPAL INVESTIGATOR
  • Maria Ribeiro da Cunha, MD

    Centro de Reabilitação do Norte (CRN)/Unidade Local de Saúde de Gaia e Espinho, E.P.E. (ULSGE)

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. Sandra I. Vieira

Study Record Dates

First Submitted

January 17, 2026

First Posted

February 3, 2026

Study Start

May 1, 2021

Primary Completion

October 16, 2023

Study Completion

October 16, 2023

Last Updated

February 3, 2026

Record last verified: 2026-01

Locations